211 related articles for article (PubMed ID: 28753776)
1. Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.
González-Billalabeitia E; Sepúlveda JM; Maroto P; Aparicio J; Arranz JA; Esteban E; Gironés R; López-Brea M; Mendez-Vidal MJ; Pinto A; Sastre J; de Prado DS; Terrasa J; Vázquez S; Powles T; Beyer J; Castellano D; Del Muro XG;
Eur Urol Focus; 2017 Apr; 3(2-3):280-286. PubMed ID: 28753776
[TBL] [Abstract][Full Text] [Related]
2. Salvage high-dose chemotherapy for germ cell tumors.
Feldman DR; Powles T
Urol Oncol; 2015 Aug; 33(8):355-62. PubMed ID: 25837842
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy plus stem cell transplantation in advanced germ cell cancer: a review.
Connolly RM; McCaffrey JA
Eur Urol; 2009 Jul; 56(1):57-64. PubMed ID: 19303697
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy for relapsed testicular germ cell tumours.
Chovanec M; Adra N; Abu Zaid M; Abonour R; Einhorn L
Nat Rev Urol; 2023 Apr; 20(4):217-225. PubMed ID: 36477219
[TBL] [Abstract][Full Text] [Related]
5. Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database.
Lorch A; Bascoul-Mollevi C; Kramar A; Einhorn L; Necchi A; Massard C; De Giorgi U; Fléchon A; Margolin K; Lotz JP; Germà-Lluch JR; Powles T; Kollmannsberger C; Beyer J
J Clin Oncol; 2011 Jun; 29(16):2178-84. PubMed ID: 21444870
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy (HDCT) as second-salvage treatment in patients with multiple relapsed or refractory germ-cell tumors.
Lorch A; Neubauer A; Hackenthal M; Dieing A; Hartmann JT; Rick O; Bokemeyer C; Beyer J
Ann Oncol; 2010 Apr; 21(4):820-825. PubMed ID: 19822531
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy as salvage treatment in germ-cell cancer: when, in whom and how.
Lorch A; Beyer J
World J Urol; 2017 Aug; 35(8):1177-1184. PubMed ID: 27678272
[TBL] [Abstract][Full Text] [Related]
8. The role of high-dose chemotherapy in the management of germ cell tumors.
Bastos DA; Feldman DR
Curr Opin Oncol; 2014 May; 26(3):284-93. PubMed ID: 24670607
[TBL] [Abstract][Full Text] [Related]
9. Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies.
Petrelli F; Coinu A; Rosti G; Pedrazzoli P; Barni S
Med Oncol; 2017 Aug; 34(8):133. PubMed ID: 28653284
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
[TBL] [Abstract][Full Text] [Related]
11. [High dose chemotherapy with autologous stem-cell support in germ cell tumors: The Instituto Português de Oncologia de Lisboa Francisco Gentil Series].
Brito M; Sanchez P; Velho S; Miranda N; Leal da Costa F; Ferreira I; Teixeira G; Guimarães A; Abecasis M; Passos Coelho JL
Acta Med Port; 2011; 24(4):533-44. PubMed ID: 22521011
[TBL] [Abstract][Full Text] [Related]
12. Should high dose chemotherapy with, or without, autologous bone marrow transplant be included in the primary treatment of testicular cancer? Round table discussion.
Grigor KM; Schmoll HJ
Eur Urol; 1993; 23(1):240-4. PubMed ID: 8386655
[TBL] [Abstract][Full Text] [Related]
13. Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT).
Taza F; Abonour R; Zaid MA; Althouse SK; Anouti B; Akel R; Hanna NH; Adra N; Einhorn LH
Clin Genitourin Cancer; 2023 Apr; 21(2):213-220. PubMed ID: 36737276
[TBL] [Abstract][Full Text] [Related]
14. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
Narayan V; Gunnarsson O; Hwang WT; Squillante CM; Nathanson KL; Stadtmauer EA; Vaughn DJ
Clin Genitourin Cancer; 2016 Dec; 14(6):524-529. PubMed ID: 27083130
[TBL] [Abstract][Full Text] [Related]
15. High-dose chemotherapy for germ cell tumors: do we have a model?
Necchi A; Lanza F; Rosti G; Martino M; Farè E; Pedrazzoli P;
Expert Opin Biol Ther; 2015 Jan; 15(1):33-44. PubMed ID: 25243977
[TBL] [Abstract][Full Text] [Related]
16. Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.
Suleiman Y; Siddiqui BK; Brames MJ; Abonour R; Einhorn LH
Biol Blood Marrow Transplant; 2013 Jan; 19(1):161-3. PubMed ID: 22892555
[TBL] [Abstract][Full Text] [Related]
17. Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?
Banna GL; De Giorgi U; Ferrari B; Castagna L; Alloisio M; Marangolo M; Rosti G; Santoro A
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1085-91. PubMed ID: 17084372
[TBL] [Abstract][Full Text] [Related]
18. Risk factors in germ cell tumour patients with relapse or progressive disease after first-line chemotherapy: evaluation of a prognostic score for survival after high-dose chemotherapy.
Sammler C; Beyer J; Bokemeyer C; Hartmann JT; Rick O
Eur J Cancer; 2008 Jan; 44(2):237-43. PubMed ID: 18055194
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy with autologous stem cell transplantation in relapsed or refractory germ cell tumours: outcomes and prognostic variables in a case series of 17 patients.
Lewin J; Dickinson M; Voskoboynik M; Collins M; Ritchie D; Toner G
Intern Med J; 2014 Aug; 44(8):771-8. PubMed ID: 24893627
[TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA).
Haugnes HS; Laurell A; Stierner U; Bremnes RM; Dahl O; Cavallin-Ståhl E; Cohn-Cedermark G
Acta Oncol; 2012 Feb; 51(2):168-76. PubMed ID: 22175254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
